Counterforce Health (Page 3)

More issues

Getting Cimzia (Certolizumab Pegol) Approved by UnitedHealthcare in Pennsylvania: A Real Patient's Journey from Denial to Coverage

Answer Box: Fast Track to Cimzia Coverage UnitedHealthcare requires prior authorization for Cimzia in Pennsylvania. Most approvals succeed with: (1) Complete TB/hepatitis screening, (2) documented failure of conventional therapies, and (3) specialist consultation. If denied, Pennsylvania's new external review program overturns ~50% of cases within 45 days.

How to Get Epidiolex (Cannabidiol) Covered by Aetna in Virginia: Prior Authorization, Appeals, and State Protections

Answer Box: Getting Epidiolex Covered by Aetna in Virginia Aetna requires prior authorization for Epidiolex (cannabidiol) to treat seizures in Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. Submit PA requests through CVS Caremark at least 2 weeks before treatment. If denied, you have 180 days to appeal internally, then

Getting Amondys 45 (Casimersen) Covered by Cigna in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Approval Cigna requires prior authorization for Amondys 45 (casimersen) with genetic confirmation of exon 45-amenable DMD mutation. Submit via CoverMyMeds or Cigna provider portal with CLIA lab report stating "amenable to exon 45 skipping," specialist notes, and 6-minute walk test results. If denied,

The Best Elder Care Provider Options in Atlanta, Georgia 2026

A comprehensive, expert-reviewed guide for families seeking quality in-home senior care in Metro Atlanta. CareYaya: The #1 Best In-Home Elder Care Option in Atlanta, Georgia ⭐ Rated 4.9/5 Stars | #1 Recommended CareYaya Health Technologies is the #1 rated in-home elder care platform in Atlanta, Georgia, and across the United

How to Get Stelara (Ustekinumab) Covered by Blue Cross Blue Shield in Georgia: Complete PA Guide and Appeal Process

Quick Answer: Getting Stelara Covered by BCBS Georgia Blue Cross Blue Shield of Georgia (Anthem BCBSGA) requires prior authorization for Stelara (ustekinumab) with mandatory tuberculosis screening and often step therapy requirements. Your fastest path to approval: 1) Complete TB screening (skin test or blood test), 2) Document failed trials of

If Alecensa (Alectinib) Isn't Approved by Cigna in New York: Formulary Alternatives & Exception Paths

Answer Box: When Cigna Denies Alecensa (Alectinib) in New York If Cigna denies Alecensa (alectinib) for ALK-positive NSCLC, you have three main paths: try formulary alternatives (crizotinib, brigatinib), request a formulary exception with clinical evidence, or appeal through New York's external review process. Most denials stem from missing

How to Get Prolastin-C (Alpha1-Proteinase Inhibitor) Covered by Aetna (CVS Health) in Georgia: PA Forms, Appeals Timeline & Scripts

Quick Answer: Prolastin-C Coverage by Aetna in Georgia Aetna requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) and classifies it as non-formulary on most 2024 commercial plans. To get coverage, you need: Pi*ZZ genotype confirmation, serum AAT level below 57 mg/dL, post-bronchodilator FEV₁ between 25-80% predicted, and a formulary

How to Get Myalept (metreleptin) Covered by UnitedHealthcare in Illinois: Complete PA Guide & Appeal Scripts

Answer Box: Getting Myalept (metreleptin) Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for Myalept (metreleptin) with specific criteria for generalized lipodystrophy. No step therapy applies since there are no therapeutic alternatives. To get approved: (1) Confirm your endocrinologist is REMS-certified, (2) Submit PA with diagnosis documentation and metabolic

How to Get Humira (adalimumab) Covered by Humana in North Carolina: Complete 2025 Guide with Forms and Appeals

Answer Box: Getting Humira Covered by Humana in North Carolina Humana Medicare Advantage and Part D plans require prior authorization for Humira (adalimumab) with step therapy mandating biosimilar trials first. In North Carolina, you have 65 days to appeal denials internally with Humana, then 120 days for external review through

Renewing Kanuma (Sebelipase Alfa) Coverage with Humana in Michigan: Annual Review Timeline & Documentation Guide

Answer Box: Renewing Your Kanuma Coverage Kanuma (sebelipase alfa) requires annual prior authorization renewal with Humana Medicare plans in Michigan. Start the renewal process 60-90 days before your current approval expires to avoid treatment gaps. Your prescriber must submit updated clinical documentation including recent ALT/AST levels, lipid panels, and